Fingerprint Dive into the research topics of 'Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: A southwest oncology group study'. Together they form a unique fingerprint.